Get the Stockscreener App
37.36
0.77%
-0.29
Pre-market:
38.50
1.14
+3.05%
Liquidia Corp stock is traded at $37.36, with a volume of 935.78K.
It is down -0.77% in the last 24 hours and up +3.69% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
See More
Previous Close:
$37.65
Open:
$37.28
24h Volume:
935.78K
Relative Volume:
0.52
Market Cap:
$3.29B
Revenue:
$158.32M
Net Income/Loss:
$-68.92M
P/E Ratio:
-44.92
EPS:
-0.8317
Net Cash Flow:
$-40.02M
1W Performance:
-1.01%
1M Performance:
+3.69%
6M Performance:
+55.50%
1Y Performance:
+200.56%
1-Day Range:
$36.61
$37.76
1-Week Range:
$36.54
$38.96
52-Week Range:
$11.26
$46.67
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
37.36 | 3.29B | 158.32M | -68.92M | -40.02M | -0.8317 |
TAK
Takeda Pharmaceutical Co Adr
|
18.29 | 57.78B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
116.80 | 49.30B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.88 | 44.03B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.33 | 34.15B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
565.70 | 24.79B | 3.18B | 1.33B | 1.04B | 27.90 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Liquidia Corporation to Participate in Upcoming Investor Conferences - ChartMill
Liquidia Corp Chairman Sells Shares: Transaction Details & AnalysisNews and Statistics - indexbox.io
Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock? - The Motley Fool
LQDA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Liquidia Corporation (LQDA) stock price, news, quote and history - Yahoo Finance UK
All eyes on Liquidia earnings as biotech eyes profitability - Investing.com
Does Liquidia Corporation (LQDA) Have the Potential to Rally 34.47% as Wall Street Analysts Expect? - Yahoo Finance
LQDA Stock Price, Quote & Chart | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill
Should Insider Stock Sale and Analyst Optimism Around Pulmonary Drugs Require Action From Liquidia (LQDA) Investors? - Yahoo Finance
Wells Fargo Lifts PT on Liquidia Corporation (LQDA) to $51 From $44 – Here’s Why - Insider Monkey
Liquidia corp director Bloch sells $2.53 million in stock By Investing.com - Investing.com Australia
Liquidia corp director Bloch sells $2.53 million in stock - investing.com
Venture fund tied to Liquidia (LQDA) trims 70K shares - stocktitan.net
Tudor Investment Corp ET AL Makes New $1.54 Million Investment in Liquidia Corporation $LQDA - MarketBeat
LQDA PE Ratio & Valuation, Is LQDA Overvalued - intellectia.ai
Liquidia Executive Sells 80,000 Shares of Stock - intellectia.ai
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M - The Motley Fool
Canaan VIII LP to sell 62,550 shares of LQDA Common Stock (LQDA) - Stock Titan
2026 Women in Business Awards: Ashley Galloway — Liquidia - The Business Journals
[144] Liquidia Corp SEC Filing - Stock Titan
Liquidia Corp (LQDA) Trading 4.64% Higher on Mar 25 - GuruFocus
Liquidia Corp CCO Moomaw sells $673k in shares - Investing.com
Scott Moomaw Sells 18,314 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat
[Form 4] Liquidia Corp Insider Trading Activity - Stock Titan
Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares - Yahoo Finance
LQDA: Wells Fargo Raises Price Target to $51, Maintains Overweig - GuruFocus
Liquidia analysts boost their forecasts after Q4 earnings - MSN
Aug Sectors: Is Liquidia Corporation stock influenced by commodity prices2026 Risk Factors & High Accuracy Buy Signal Tips - baoquankhu1.vn
Liquidia Corporation $LQDA Shares Sold by Mirabella Financial Services LLP - MarketBeat
Liquidia Retail Buzz Surges After BofA Raises Price Target to $25 On Yutrepia FDA Nod - msn.com
Can Liquidia Corporation (LQDA) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Wall Street Analysts See a 35.35% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High? - Yahoo Finance
Liquidia (NASDAQ:LQDA) Announces Quarterly Earnings Results, Beats Estimates By $0.14 EPS - MarketBeat
Why Liquidia (LQDA) Is Down 5.1% After Swing to Profit and $125 Million Shelf Filings - Yahoo Finance
Recent Insider Transactions at Liquidia Corp - TradingView
Liquidia (LQDA) CMO trims stake with 35,365-share open-market sale - Stock Titan
Liquidia (LQDA) HR chief sells 16,261 shares, keeps 148,397 - Stock Titan
Liquidia (LQDA) director sells 20,000 shares after exercising options - Stock Titan
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It - MSN
Farallon Capital Management LLC Purchases 4,326,876 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia (LQDA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Rule 144: LQDA (NASDAQ) notice lists 40,359-share planned sale - Stock Titan
Rajeev Saggar sells 21,142 LQDA shares (NASDAQ: LQDA) reported on Form 144 - Stock Titan
Insider Sale Notices at LQDA: 13,165-Share Disposition and Issuer Awards (LQDA) - Stock Titan
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
1.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):